Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2007;115:827-828
doi: 10.1161/CIRCULATIONAHA.106.686238
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Michos, E. D.
Right arrow Articles by Blumenthal, R. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Michos, E. D.
Right arrow Articles by Blumenthal, R. S.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Related Collections
Right arrow Primary prevention
Right arrow Risk Factors
Right arrow Epidemiology

(Circulation. 2007;115:827-828.)
© 2007 American Heart Association, Inc.


Editorial

Vitamin D Supplementation and Cardiovascular Disease Risk

Erin D. Michos, MD; Roger S. Blumenthal, MD

From the Ciccarone Preventive Cardiology Center, Johns Hopkins University School of Medicine, Baltimore, Md.

Correspondence to Roger S. Blumenthal, MD, FACC, Director, Ciccarone Preventive Cardiology Center, Blalock 524 C, Division of Cardiology, Johns Hopkins Hospital, 600 N Wolfe St, Baltimore, MD 21287. E-mail rblument@jhmi.edu


Key Words: Editorials • calcium • cardiovascular diseases • prevention • risk factors • vitamin D


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

Many studies,1,2 but not all, have shown that low bone density is associated with increased cardiovascular disease (CVD) risk. Vitamin D deficiency is common in the elderly and is associated with osteoporosis; however, the association of endogenous 25-OH vitamin D (25-OH D) levels with CVD events is controversial.3,4 CVD rates are higher during winter seasons and at increased geographic latitudes where average serum vitamin D levels are lowest.5 Low 25-OH D levels have been found in stroke6 and heart failure patients.7 Moreover, 25-OH D deficiency is associated with hypertension, obesity,8 glucose intolerance,8 and the metabolic syndrome,9 which may be responsible, at least in part, for its association with increased CVD risk.

Article p 846

Although vitamin D supplementation improves bone strength, elevated serum vitamin D levels may be associated with lower levels of vascular calcification. In subjects at moderately high risk for coronary heart disease, endogenous serum vitamin D levels were inversely correlated with the extent of coronary artery calcification as determined by cardiac computed tomography.10 Vitamin D also has intriguing antiinflammatory properties11 that have potential therapeutic benefit in several autoimmune diseases and allograft rejection. In 2 small clinical trials,12,13 vitamin D supplementation lowered C-reactive protein levels. Additionally, 1,25(OH)2D induces relaxation of vascular smooth muscle cells and downregulation of renin production by the kidneys. Finally, the observation of reduced mortality risk with 1,25(OH)2 D supplements among patients with renal failure14 supports a possible CVD protective role of vitamin D. Accordingly, it is reasonable to hypothesize that vitamin D supplementation . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
J. Lipid Res.Home page
A. H. Lichtenstein
Nutrient supplements and cardiovascular disease: a heartbreaking story
J. Lipid Res., April 1, 2009; 50(Supplement): S429 - S433.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
J. P Reis, E. D Michos, D. von Muhlen, and E. R Miller III
Differences in vitamin D status as a possible contributor to the racial disparity in peripheral arterial disease
Am. J. Clinical Nutrition, December 1, 2008; 88(6): 1469 - 1477.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
J. Andrade, L. Er, A. Ignaszewski, and A. Levin
Exploration of Association of 1,25-OH2D3 with Augmentation Index, a Composite Measure of Arterial Stiffness
Clin. J. Am. Soc. Nephrol., November 1, 2008; 3(6): 1800 - 1806.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Pilz, W. Marz, B. Wellnitz, U. Seelhorst, A. Fahrleitner-Pammer, H. P. Dimai, B. O. Boehm, and H. Dobnig
Association of Vitamin D Deficiency with Heart Failure and Sudden Cardiac Death in a Large Cross-Sectional Study of Patients Referred for Coronary Angiography
J. Clin. Endocrinol. Metab., October 1, 2008; 93(10): 3927 - 3935.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. J. Wang, M. J. Pencina, S. L. Booth, P. F. Jacques, E. Ingelsson, K. Lanier, E. J. Benjamin, R. B. D'Agostino, M. Wolf, and R. S. Vasan
Vitamin D Deficiency and Risk of Cardiovascular Disease
Circulation, January 29, 2008; 117(4): 503 - 511.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
G. S. Getz and C. A. Reardon
Nutrition and Cardiovascular Disease
Arterioscler Thromb Vasc Biol, December 1, 2007; 27(12): 2499 - 2506.
[Abstract] [Full Text] [PDF]